Gilles de la Tourette syndrome as a paradigmatic neuropsychiatric disorder.
Cavanna AE.
CNS Spectr. 2018 Jun;23(3):213-218. doi: 10.1017/S1092852918000834. Epub 2018 May 21.
Gilles de la Tourette syndrome - A treatable condition?
Hartmann A, Martino D, Murphy T.
Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):446-454. doi: 10.1016/j.neurol.2016.07.004. Epub 2016 Jul 28.
A neural noise account of Gilles de la Tourette syndrome.
Münchau A, Colzato LS, AghajaniAfjedi A, Beste C.
Neuroimage Clin. 2021;30:102654. doi: 10.1016/j.nicl.2021.102654. Epub 2021 Mar 29.
Cannabis-based medicine in treatment of patients with Gilles de la Tourette syndrome.
Szejko N, Saramak K, Lombroso A, Müller-Vahl K.
Neurol Neurochir Pol. 2022;56(1):28-38. doi: 10.5603/PJNNS.a2021.0081. Epub 2021 Oct 28.
[Gilles de la Tourette Syndrome: Symptoms, Causes and Therapy].
Jakubovski E, Müller-Vahl KR.
Psychother Psychosom Med Psychol. 2017 Jun;67(6):252-268. doi: 10.1055/s-0043-103269. Epub 2017 Jun 22.
Gilles de la Tourette syndrome.
Gravino G.
Ann Clin Psychiatry. 2013 Nov;25(4):297-306.
The neuropsychiatry of Gilles de la Tourette syndrome: The etat de l'art.
Cavanna AE.
Rev Neurol (Paris). 2018 Nov;174(9):621-627. doi: 10.1016/j.neurol.2018.06.006. Epub 2018 Aug 8.
European clinical guidelines for Tourette syndrome and other tic disorders: summary statement.
Müller-Vahl KR, Szejko N, Verdellen C, Roessner V, Hoekstra PJ, Hartmann A, Cath DC.
Eur Child Adolesc Psychiatry. 2022 Mar;31(3):377-382. doi: 10.1007/s00787-021-01832-4. Epub 2021 Jul 10.
[Gilles-de-la-Tourette syndrome].
Schauenburg H, Dressler D.
Nervenarzt. 1992 Aug;63(8):453-61.
Gilles de la Tourette syndrome.
Arzimanoglou AA.
J Neurol. 1998 Dec;245(12):761-5. doi: 10.1007/s004150050284.
